Metraipolis › archive › dc_fea2b49ef9b2
Two vs three cycles of neoadjuvant immunochemotherapy for resectable non-small-cell lung cancer: a real-world population-based study — Europe PMC PMID:41333472
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41333472
- DOI
- 10.3389/fimmu.2025.1654830
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T12:38:55.171Z
- SHA-256 of the archived text
ce020c312da80cf5a964a30b182c9cf597e77a8cf16091c931a7c22173b7609c- Stable URL of this page
https://metraipolis.com/documento/dc_fea2b49ef9b2
How to cite
Two vs three cycles of neoadjuvant immunochemotherapy for resectable non-small-cell lung cancer: a real-world population-based study — Europe PMC PMID:41333472 — Europe PMC (en), https://europepmc.org/article/MED/41333472 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fea2b49ef9b2 (Metraipolis archive dc_fea2b49ef9b2, sha256 ce020c312da80cf5a964a30b182c9cf597e77a8cf16091c931a7c22173b7609c)
BibTeX
@misc{dcfea2b49ef9b2,
title = {Two vs three cycles of neoadjuvant immunochemotherapy for resectable non-small-cell lung cancer: a real-world population-based study — Europe PMC PMID:41333472},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41333472},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fea2b49ef9b2; sha256 ce020c312da80cf5a964a30b182c9cf597e77a8cf16091c931a7c22173b7609c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41333472. Agents can read the archived copy with the MCP tool read_document.